
Pro Medicus pain alert
There is more soreness ahead for Australian investors who avoid the US radiology juggernaut.
There is more soreness ahead for Australian investors who avoid the US radiology juggernaut.
Yet more tumult for HMC Capital, as its energy transition strategy follows its hospital and data centre funds into the market doghouse.
Xero throws US$3B at Melio in a high-stakes gamble that may blow up spectacularly.
Urged on by America's tax-shifting tech mafia, President Trump's 'One Big Beautiful Bill' will punish Aussie companies and super funds.
Domain’s hype falls flat as CoStar steps in to clean up the mess.
Investors now expect that a material amount of IDP's revenue from the last six months now won't materialise.
With its investigation into the dominant property advertising portal, the ACCC is not fooling around.
As the US experience demonstrates, PE and hospitals are a terrible mix.
Dexus' airport fund investors may be trapped on a one-way flight to a valuation downgrade.
ASIC has finally taken aim at Macquarie's market transgressions, but what took the corporate cop this long?
The Anzac Day brouhaha over the club's aborted welcome to country is the last thing Peter V'Landys needs right now.